
    
      Subjects will be implanted with ACRYSOFÂ® IQ Monofocal IOL Model SN60WF. Standard clinical
      practice will be followed for pre-operative testing, IOL power estimation and IOL
      implantation. Only one eye will be enrolled in the study per surgeon determination. The eye
      will undergo both an automated and manual manifest refraction assessment at 3 months
      postoperative.
    
  